Trademarkia Logo

Australia

AU$
XAVERZAL
Cancelled: Cancelled at the request of IB

Last updated on 14 Dec 2017

Owner Info

Portola Pharmaceuticals, Inc.

270 East Grand Avenue

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

1699262 filed on 8 Apr 2015

Correspondent

Harold Milstein, Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

XAVERZAL

Classification Information


Class [005]
Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, he Read More

Mark Details


Serial Number

1699262

Registered On

8 Apr 2015

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

8 Oct 2014

Mark Type

US

Legal History


Show more

Status DateAction Taken
14th Dec 2017Cancellation of Entry in Register Published
7th Dec 2017Cancel IP Right
7th Sept 2017General Correspondence (Application or Registration)
24th Sept 2015IP Right Registration Published
17th Sept 2015Register Trade Mark
17th Sept 2015Application Status
9th Jul 2015IP Right Acceptance Published
6th Jul 2015Clear Examination report approved
6th Jul 2015User Created Notice correspondence sent
6th Jul 2015Application Accepted correspondence sent